توضیحاتی در مورد کتاب Schlossberg's Clinical Infectious Disease [Team-IRA] [True PDF]
نام کتاب : Schlossberg's Clinical Infectious Disease [Team-IRA] [True PDF]
ویرایش : 3
عنوان ترجمه شده به فارسی : بیماری عفونی بالینی Schlossberg [Team-IRA] [PDF واقعی]
سری :
نویسندگان : Cheston B. Cunha (editor)
ناشر : Oxford University Press
سال نشر : 2022
تعداد صفحات : 1521
ISBN (شابک) : 0190888369 , 9780190888367
زبان کتاب : English
فرمت کتاب : pdf
حجم کتاب : 28 مگابایت
بعد از تکمیل فرایند پرداخت لینک دانلود کتاب ارائه خواهد شد. درصورت ثبت نام و ورود به حساب کاربری خود قادر خواهید بود لیست کتاب های خریداری شده را مشاهده فرمایید.
فهرست مطالب :
Cover
Schlossberg’sClinicalInfectiousDisease
Copyright
Dedication
Contents
Preface
Contributors
Section 1 Clinical syndromes: General
1. Fever of unknown origin
2. Sepsis
3. Chronic fatigue syndrome
Section 2 Clinical syndromes: Head and neck
4. Pharyngotonsillitis
5. Infectious thyroiditis
6. Otitis
7. Sinusitis
8. Dental infections
9. Salivary and lacrimal gland infections
10. Deep neck infections
Section 3 Clinical syndromes: Eye
11. Conjunctivitis
12. Keratitis
13. Iritis
14. Retinitis
15. Endophthalmitis
16. Periocular and retro-orbital infections
Section 4 Clinical syndromes: Skin and lymph nodes
17. Fever and rash
18. Toxic shock syndrome and Kawasaki disease
19. Viral exanthems
20. Skin ulcer and pyoderma
21. Cellulitis and erysipelas
22. Deep soft-tissue infections: Necrotizing fasciitis and gas gangrene
23. Human and animal bites
24. Lice, scabies, and myiasis
25. Tungiasis and bed bugs
26. Superficial fungal infection of skin and nails
27. Eumycetoma
28. Lymphadenopathy/Lymphadenitis
Section 5 Clinical syndromes: Respiratory tract
29. Bronchitis
30. Croup, supraglottitis, and laryngitis
31. Atypical pneumonia
32. Community-acquired pneumonia
33. Nosocomial pneumonia
34. Aspiration pneumonia
35. Lung abscess
36. Empyema and bronchopleural fistula
Section 6 Clinical syndromes: Heart and blood vessels
37. Endocarditis
38. Acute pericarditis
39. Myocarditis
40. Mediastinitis
41. Vascular infection
42. Infections of cardiovascular implantable devices
Section 7 Clinical syndromes: Gastrointestinal tract, liver, and abdomen
43. Acute viral hepatitis
44. Chronic viral hepatitis
45. Biliary infection: Cholecystitis, cholangitis
46. Pyogenic liver abscess
47. Infectious complications in acute pancreatitis
48. Esophageal infections
49. Gastroenteritis
50. Food poisoning
51. Clostridioides (Clostridium) difficile
52. Sexually transmitted enteric infections
53. Acute appendicitis
54. Diverticulitis
55. Abdominal abscess
56. Splenic abscess
57. Peritonitis
58. Whipple’s disease and sprue
Section 8 Clinical syndromes: Genitourinary tract
59. Urethritis and dysuria
60. Vaginitis and cervicitis
61. Epididymo-orchitis
62. Genital ulcer adenopathy syndrome
63. Prostatitis
64. Pelvic inflammatory disease
65. Urinary tract infection
66. Candiduria
67. Focal renal infections and papillary necrosis
Section 9 Clinical syndromes: Musculoskeletal system
68. Infection of native and prosthetic joints
69. Bursitis
70. Acute and chronic osteomyelitis
71. Polyarthritis
72. Infectious polymyositis
73. Iliopsoas abscess
Section 10 Clinical syndromes: Neurologic system
74. Bacterial meningitis
75. Aseptic meningitis
76. Viral encephalitis
77. Intracranial suppuration
78. Spinal epidural abscess
79. Myelitis and peripheral neuropathy
80. Reye syndrome
81. Progressive multifocal leukoencephalopathy
82. Cerebrospinal fluid shunt infections
Section 11 The susceptible host
83. Evaluation of suspected immunodeficiency
84. Infection in the neutropenic patient
85. Infections in patients with neoplastic disease
86. Corticosteroids, cytotoxic agents
87. Biologics
88. Infection in transplant patients
89. Diabetes and infection
90. Infectious complications in the injection and non-injection drug user
91. Infections in the alcoholic
92. Infection in the elderly
93. Neonatal infection
94. Pregnancy and the puerperium: Infectious risks
95. Dialysis-related infection
96. Asplenia-associated Infections
Section 12 HIV
97. HIV infection: Initial evaluation and monitoring
98. HIV: Antiretroviral therapy
99. Immune reconstitution inflammatory syndrome
100. Opportunistic infections in HIV
101. Prophylaxis of opportunistic infections in HIV disease
Section 13 Nosocomial infection
102. Percutaneous injury: Risks and management
103. Hospital-acquired fever
104. Transfusion-related infection
105. Intravascular catheter-related infection
106. Infections associated with urinary catheters
Section 14 Infections related to surgery and trauma
107. Postoperative wound infection
108. Trauma-related infection
109. Infected implants
110. Infection in the burn-injured patient
Section 15 Prevention of infection
111. Nonsurgical antimicrobial prophylaxis
112. Surgical prophylaxis
113. Immunizations
Section 16 Travel and recreation
114. Advice for travelers
115. Fever in the returning traveler
116. Systemic infection from animals
117. Tick-borne disease
118. Recreational water exposure
119. Travelers’ diarrhea
Section 17 Bioterrorism
120. Bioterrorism
Section 18 Specific organisms: Bacteria
121. Actinomycosis
122. Anaerobic infections
123. Anthrax
124. Bartonella bacilliformis
125. Cat scratch disease and other Bartonella infections
126. Bordetella
127. Branhamella-Moraxella
128. Brucellosis
129. Campylobacter
130. Clostridium
131. Corynebacteria
132. Enterobacteriaceae
133. Enterococcus
134. Erysipelothrix
135. HACEK
136. Helicobacter pylori
137. Neisseria gonorrhoeae
138. Haemophilus
139. Legionellosis
140. Leprosy
141. Meningococcus and miscellaneous neisseriae
142. Listeria
143. Nocardia
144. Pasteurella multocida
145. Pneumococcus
146. Pseudomonas, stenotrophomonas, and burkholderia
147. Rat-bite fevers
148. Salmonella
149. Staphylococcus
150. Streptococcus groups A, B, C, D, and G
151. Viridans streptococci
152. Poststreptococcal immunologic complications
153. Shigella
154. Tularemia
155. Tuberculosis
156. Nontuberculous mycobacteria
157. Vibrios
158. Yersinia
159. Miscellaneous gram-positive organisms
160. Miscellaneous gram-negative organisms
Section 19 Specific organisms: Spirochetes
161. Syphilis and other treponematoses
162. Lyme disease
163. Borreliosis
164. Leptospirosis
Section 20 Specific organisms: Mycoplasma and Chlamydia
165. Mycoplasma
166. Chlamydia pneumoniae
167. Chlamydophila psittaci (psittacosis)
Section 21 Specific organisms: Rickettsia, Ehrlichia, and Anaplasma
168. Rickettsial infections
169. Ehrlichiosis and anaplasmosis
Section 22 Specific organisms: Fungi
170. Candidiasis
171. Aspergillus
172. Mucormycosis (and entomophthoramycosis)
173. Sporotrichum
174. Cryptococcus
175. Histoplasmosis
176. Blastomycosis
177. Coccidioidomycosis
178. Pneumocystis jirovecii (carinii)
179. Miscellaneous (emerging) fungi and algae
Section 23 Specific organisms: Viruses
180. Cytomegalovirus
181. Dengue
182. Enteroviruses
183. Epstein-Barr virus and other causes of the infectious mononucleosis syndrome
184. Hantavirus cardiopulmonary syndrome
185. Herpes simplex 1 and 2
186. Human herpes virus 6, 7, 8
187. Influenza
188. Coronavirus-19
189. Papillomavirus in oro-genital infection
190. Acute and chronic parvovirus infection
191. Rabies
192. Varicella-zoster virus
193. Viral hemorrhagic fevers
Section 24 Specific organisms: Parasites
194. Intestinal roundworms
195. Tissue nematodes
196. Schistosomes and other trematodes
197. Tapeworms (cestodes)
198. Toxoplasma
199. Malaria
200. Babesiosis
201. Trypanosomes and leishmania
202. Intestinal protozoa
203. Extraintestinal amebic infection
Section 25 Antimicrobial therapy: General considerations
204. Principles of antibiotic therapy
205. Antibacterial agents
206. Principles and practice of antimicrobial stewardship
207. Antifungal therapy
208. Antiviral therapy
209. Probiotics: an update
210. Hypersensitivity to antibiotics
211. Antimicrobial agent tables
Index